CBIZ (NYSE:CBZ – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 2.640-2.690 for the period, compared to the consensus earnings per share estimate of 2.640. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $2.1 billion. CBIZ also updated its FY24 guidance to $2.64-$2.69 EPS.
Analysts Set New Price Targets
A number of analysts have recently commented on the company. Sidoti raised CBIZ from a “neutral” rating to a “buy” rating and lifted their price target for the company from $80.00 to $86.00 in a research note on Monday, August 12th. StockNews.com downgraded shares of CBIZ from a “hold” rating to a “sell” rating in a research report on Thursday, September 5th.
Read Our Latest Stock Report on CBIZ
CBIZ Trading Up 0.1 %
CBIZ (NYSE:CBZ – Get Free Report) last announced its earnings results on Tuesday, October 29th. The business services provider reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.08. CBIZ had a net margin of 7.12% and a return on equity of 14.58%. The business had revenue of $438.90 million during the quarter, compared to the consensus estimate of $440.16 million. During the same quarter last year, the firm earned $0.66 earnings per share. CBIZ’s quarterly revenue was up 6.9% on a year-over-year basis. Research analysts predict that CBIZ will post 2.64 earnings per share for the current fiscal year.
CBIZ Company Profile
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Read More
- Five stocks we like better than CBIZ
- The 3 Best Fintech Stocks to Buy Now
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Quiet Period Expirations Explained
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Best Aerospace Stocks Investing
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.